Navigation Links
New Jersey Health Foundation/The Nicholson Foundation award $50,000 grant to advance a device to promote less traumatic tooth removal
Date:12/16/2015

NEW BRUNSWICK, N.J., Dec. 16, 2015 /PRNewswire-USNewswire/ -- Antonio Valdevit, PhD, an assistant professor in the Department of Biomedical Engineering, Chemistry and Biological Sciences at Stevens Institute of Technology, has received a $50,000 Innovation Grant from New Jersey Health Foundation/The Nicholson Foundation to advance research into a medical device that could reduce local trauma and improve outcomes for people requiring tooth extractions, announced James M. Golubieski, president of New Jersey Health Foundation.

The technology can be particularly important for people needing dental implants or for anyone who must avoid the risk of oral bleeding due to underlying medical conditions.

"Tooth extraction has been relatively unchanged for decades," explained George F. Heinrich, M.D., vice chair and CEO of New Jersey Health Foundation. "With the advent of numbing agents to reduce patient pain, the procedure has undergone little innovation with the exception of instrument refinement.  This novel technology employs vibration to loosen and extract teeth while reducing local trauma."

Dr. Valdevit has identified a mechanism that employs vibratory motion to loosen the tooth with a piezoelectric actuator that can be incorporated into existing instruments currently used in the dental field. 

"Current methods of extraction result in significant recovery time due to local trauma," Dr. Valdevit explains. "And in some cases, neighboring teeth may be subject to damage.  Our method of vibratory extraction will reduce or eliminate the need for surgical cutting of soft tissue and significantly reduce the mechanical forces needed to extract the tooth."

According to Dr. Valdevit, not only is the technology useful for humans, but also for tooth extractions necessary in the veterinary field.

For more information, contact Mike Wiley, vice president, at (908) 731-6612 or mwiley@njhf.org

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies in New Jersey headed toward commercialization.

About Stevens Institute of Technology
Stevens Institute of TechnologyThe Innovation University®, is a premier, private research university situated in Hoboken, N.J. overlooking the Manhattan skyline. Founded in 1870, technological innovation has been the hallmark and legacy of Stevens' education and research programs for more than 140 years. Within the university's three schools and one college, more than 6,300 undergraduate and graduate students collaborate with more than 380 faculty members in an interdisciplinary, student-centric, entrepreneurial environment to advance the frontiers of science and leverage technology to confront global challenges. Stevens is home to four national research centers of excellence, as well as joint research programs focused on critical industries such as healthcare, energy, finance, defense, maritime security, STEM education and coastal sustainability. The university is consistently ranked among the nation's elite for return on investment for students, career services programs and mid-career salaries of alumni. Stevens is in the midst of a 10-year strategic plan, The Future. Ours to Create, designed to further extend the Stevens legacy to create a forward-looking and far-reaching institution with global impact.

 


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Soligenix Receives $490,000 in Non-Dilutive Financing from New Jerseys Technology Business Tax Certificate Transfer Program
2. New Jersey Health Foundation/The Nicholson Foundation award $300,000 for innovative projects at major NJ universities
3. Chugai Pharmaceutical Opens a North American Hub in New Jersey
4. Viralytics and Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. to Collaborate on Combination Clinical Trial of CAVATAK(TM) and KEYTRUDA(R) in Lung and Bladder Cancer
5. Urgent Care Provider CityMD Expands Into New Jersey
6. Cardiac Science Provides AEDs to New Jersey EMS Task Force to Safeguard Crowds for Popes Visit
7. New Jersey Lab Equipment Testing Company Welcomes GE Product Line
8. California Lags Behind On Requiring Physicians To Check Database Before Prescribing Powerful, Addictive Medications As New Jersey Becomes Tenth State To Make It Mandatory, Says Consumer Watchdog
9. Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey
10. Partnership for Drug-Free Kids Brings Life-Saving Kits and Training to New Jersey Families
11. INSIGHTEC Announces BCBS North Carolina and Horizon BCBS of New Jersey Published Positive Coverage of MRgFUS Treatments for Pain Palliation of Bone Cancer Metastases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... ... July 10, 2020 , ... COMPLIANCY GROUP in ... for Business Associates. Business associates create, receive, transmit, store, and maintain protected health ... are required to be HIPAA compliant, ensuring the confidentiality, integrity, and availability of ...
(Date:7/10/2020)... ... July 09, 2020 , ... The team at ... to their completely redesigned website. The new site offers a multitude of user enhancements ... free downloadable information available with easy to navigate menus which will allow patients to ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... business and technology for the pharmaceutical industry throughout North America has launched ... highest quality pharmaceutical products. QC Corner will feature content from ...
Breaking Medicine Technology:
(Date:7/7/2020)... ... July 07, 2020 , ... The Germ-Fogger™ disinfecting ... to efficiently sanitize large surfaces is now available in Mexico and Latin America. ... in that region. , In this era of worldwide pandemic, the ability to ...
(Date:7/2/2020)... ... July 02, 2020 , ... Temprian, a spinoff from Northwestern ... Its lead indication is vitiligo. Vitiligo patients develop progressive depigmentation of the skin. ... vitiligo is equally prevalent in all ethnic groups, it is most visible and ...
(Date:7/2/2020)... SHELTON, Conn. (PRWEB) , ... July 02, 2020 ... ... closure of many businesses, including dental offices for non-emergency work. In conjunction with ... released reopening guidelines for Connecticut dental practices in mid-May. , Due to ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to ... of Medicine at the University of Massachusetts Medical School- Baystate and Ann Gaffey, ... the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in ...
(Date:6/28/2020)... ... ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use in pathology ... expression to assess response in patients treated with Bristol Myers Squibb’s PD-1 inhibitor, nivolumab ... (AACR) Annual Meeting. AACR was held June 22 to June 24. , The key ...
Breaking Medicine News(10 mins):